Home
Gyroscope Therapeutics

Gyroscope Therapeutics Market Share Analysis for July 2026

Working together, we can reimagine medicine to improve and extend people’s lives.

Health > Biotechnology and Pharmaceuticals

Domaingyroscopetx.com

Year Founded2016

Employees51 - 200

Annual Revenue$2M - $5M

Gyroscope Therapeutics

Gyroscope Therapeutics (including company regionals)

gyroscopetx.com

See more website traffic and engagement information

Gyroscope Therapeutics Revenue up to July 2026 is 2M - 5M

revenue generated by Gyroscope Therapeutics top domains

Gyroscope Therapeutics top domains revenue over 3 years

Revenue for Gyroscope Therapeutics top domains

gyroscopetx.com2M - 5M

See more with Sales Intelligence

Total visits to Gyroscope Therapeutics's top domains

Understand Gyroscope Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Gyroscope Therapeutics's top domains

Analyze Gyroscope Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Gyroscope Therapeutics's top domains

See how Gyroscope Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Gyroscope Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Gyroscope Therapeutics

These are the website technologies, by industry, used by Gyroscope Therapeutics top domains

Widget (8)

Twemoji

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Recruitment (2)

Workable

More Technologies

10

See all

News & Signals from Gyroscope Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovartis AG acquired Gyroscopetx on Dec 1st '21.In December 2021, Novartis announced the acquisition of Gyroscope Therapeutics, the UK-based company behind an investigational gene therapy for geographic atrophy that is the focus of key clinical trials in Australia.

NewsNovartis AG acquired Gyroscope Therapeutics Limited for $1.5B on Dec 1st '21.LONDON - 22 December 2021 - Gyroscope Therapeutics Holdings plc ("Gyroscope"), a clinical-stage gene therapy company focused on diseases of the eye, today announced an agreement has been reached for Novartis to acquire Gyroscope for an upfront payment of $800 million (£604 million) and up to $700 million (£528 million) potentially due upon the achievement of certain milestones.

NewsNovartis AG acquired Gyroscopetx for $1.5B on Dec 22nd '21.Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on diseases of the eye, today announced an agreement has been reached for Novartis to acquire Gyroscope for an upfront payment of $800 million (£604 million) and up to $700 million (£528 million) potentially due upon the achievement of certain milestones.